Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68(6):394–424.
Roukos D. Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000;26(4):243–55.
Ang J, Hu L, Huang P-T, Wu J-X, Huang L-N, Cao C-H, Zheng Y-X, Chen L. Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy. World J Gastroenterol WJG. 2012;18(47):7026.
Wang X-Z, Zeng Z-Y, Ye X, Sun J, Zhang Z-M, Kang W-M. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. World J Gast Oncol. 2020;12(1):37.
Fu J, Tang L, Li Z-Y, Li X-T, Zhu H-F, Sun Y-S, Ji J-F. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy. Eur J Radiol. 2020;128: 108974.
Li Z, Zhang D, Dai Y, Dong J, Wu L, Li Y, Cheng Z, Ding Y, Liu Z. Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: a pilot study. Chin J Cancer Res. 2018;30(4):406.
Lauridsen CA, Falletin E, Hansen ML, Law I, Federspiel B, Bæksgaard L, Svendsen LB, Nielsen MB. Computed Tomography (CT) Perfusion as an early prognostic marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer-a prospective study. PLoS ONE. 2014;9:1–10.
Virendra K, Yuhua G, Satrajit B. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30(9):1234–48.
Xu Q, Sun Z, Li X, Ye C, Zhou C, Zhang L, Lu G. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy. Eur Radiol. 2021. https://doi.org/10.1007/s00330-021-07962-2.
Article PubMed PubMed Central Google Scholar
Wang W, Peng Y, Feng X, Zhao Y, Seeruttun SR, Zhang J, Cheng Z, Li Y, Liu Z, Zhou Z. Development and validation of a computed tomography-based radiomics signature to predict response to neoadjuvant chemotherapy for locally advanced gastric cancer. JAMA Netw Open. 2021;4(8):e2121143–e2121143.
Sun K-Y, Hu H-T, Chen S-L, Ye J-N, Li G-H, Chen L-D, Peng J-J, Feng S-T, Yuan Y-J, Hou X. CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer. 2020;20:1–11.
Kather JN, Krisam J, Charoentong P, Luedde T, Herpel E, Weis C-A, Gaiser T, Marx A, Valous NA, Ferber D. Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study. PLoS Med. 2019;16(1): e1002730.
Peng H, Dong D, Fang M-J, Li L, Tang L-L, Chen L, Li W-F, Mao Y-P, Fan W, Liu L-Z. Prognostic value of deep learning PET/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma. Clin Cancer Res. 2019;25(14):4271–9.
Mobadersany P, Yousefi S, Amgad M, Gutman DA, Barnholtz-Sloan JS, Vega JEV, Brat DJ, Cooper LA. Predicting cancer outcomes from histology and genomics using convolutional networks. Proc Natl Acad Sci. 2018;115(13):E2970–9.
Jiang Y, Liang X, Wang W, Chen C, Yuan Q, Zhang X, Li N, Chen H, Yu J, Xie Y. Noninvasive prediction of occult peritoneal metastasis in gastric cancer using deep learning. JAMA Netw Open. 2021;4(1):e2032269–e2032269.
Jin C, Jiang Y, Yu H, Wang W, Li B, Chen C, Yuan Q, Hu Y, Xu Y, Zhou Z. Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer. Br J Surg. 2021;108(5):542–9.
Gao Y, Zhang Z-D, Li S, Guo Y-T, Wu Q-Y, Liu S-H, Yang S-J, Ding L, Zhao B-C, Li S. Deep neural network-assisted computed tomography diagnosis of metastatic lymph nodes from gastric cancer. Chin Med J. 2019;132(23):2804.
Amin MBES, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
NCCN duideline. https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients.
Jia F, Lei TA, Zyl C, Xtl A, Hfz B, Yss A, Jfj C. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy—ScienceDirect. Eur J Radiol. 2020. https://doi.org/10.1016/j.ejrad.2020.108974.
Yang C, Jiang ZK, Liu LH, Zeng MS. Pre-treatment ADC image-based random forest classifier for identifying resistant rectal adenocarcinoma to neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2020. https://doi.org/10.1007/s00384-019-03455-3.
Zhou X, Yi Y, Liu Z, Cao W, Tian J. Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07300-3.
Article PubMed PubMed Central Google Scholar
Jiang Y, Jin C, Yu H, Wu J, Li R. Development and validation of a deep learning CT signature to predict survival and chemotherapy benefit in gastric cancer: a multicenter, retrospective study. Ann Surg. 2020. https://doi.org/10.1097/SLA.0000000000003778.
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proceedings of the IEEE conference on computer vision and pattern recognition, 2016. pp 770–778
Dao T, Gu A, Ratner AJ, Smith V, Sa CD, Ré C. A Kernel Theory of Modern Data Augmentation. PMLR, 2019. pp 1528–1537
Pan SJ, Qiang Y. A Survey on Transfer Learning. IEEE Trans Knowl Data Eng. 2010;22(10):1345–59.
Steiner B, Devito Z, Chintala S, Gross S, Paszke A, Massa F, Lerer A, Chanan G, Lin Z, Yang E. PyTorch: an imperative style, high-performance deep learning library. Neural information processing systems; 2019. p. 8026–37.
Zhou B, Khosla A, Lapedriza A, Oliva A, Torralba A Learning deep features for discriminative localization. In: Proceedings of the IEEE conference on computer vision and pattern recognition, 2016. pp 2921–2929
Sauerbrei W, Boulesteix A-L, Binder H. Stability investigations of multivariable regression models derived from low-and high-dimensional data. J Biopharm Stat. 2011;21(6):1206–31.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.
Cheong J-H, Yang H-K, Kim H, Kim WH, Kim Y-W, Kook M-C, Park Y-K, Kim H-H, Lee HS, Lee KH. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Lancet Oncol. 2018;19(5):629–38.
Wu J, Li B, Sun X, Cao G, Rubin DL, Napel S, Ikeda DM, Kurian AW, Li R. Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with dysregulated signaling pathways and poor survival in breast cancer. Radiology. 2017;285(2):401–13.
Wu J, Cao G, Sun X, Lee J, Rubin DL, Napel S, Kurian AW, Daniel BL, Li R. Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy. Radiology. 2018;288(1):26–35.
Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer. BMC Cancer. 2017;17(1):737.
Chen XZ, Zhang WK, Yang K, Wang LL, Liu J, Wang L, Hu JK, Zhang B, Chen ZX, Chen JP. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep. 2012;39(9):9031–9.
Yang AP, Liu J, Lei HY, Zhang QW, Zhao L, Yang GH. CA72–4 combined with CEA, \\ and CAl9–9 improves the sensitivity for the early diagnosis of gastric cancer. Clin Chim Acta. 2014. https://doi.org/10.1016/j.cca.2014.07.034.
Takekazu Y, Shunkichi K, Akira K, Koichi K, Takayoshi H, Norishige T, Masakazu M. Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer. Jpn J Clin Oncol. 1999;11:550–5.
Sun Z, Zhang N. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J Surg Oncol. 2014;12(1):397.
留言 (0)